Does Ethyl Chloride Spray Work?
Launched by UNIVERSITY OF CHICAGO · Oct 18, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using Ethyl Chloride spray can help reduce pain and anxiety for patients receiving corticosteroid injections. These injections are often used to treat conditions like arthritis and tendon issues, but many patients feel nervous about the discomfort caused by the needle and the medication itself. The trial aims to see if the spray can make the experience more comfortable for patients getting these injections for the first time.
To participate in this study, you need to be at least 18 years old and about to receive your first corticosteroid injection in your arm or leg. Unfortunately, if you’ve had an injection before, you wouldn’t be eligible to join this trial. If you decide to participate, you can expect to use the Ethyl Chloride spray before the injection to see if it helps ease any pain or worry you might have. The trial is not yet recruiting, so there’s no immediate action needed, but it’s an opportunity for those who meet the criteria to help find ways to improve this common medical procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • Receiving a corticosteroid injection in an upper or lower extremity (to include soft tissue and joint injections) for the first time
- Exclusion Criteria:
- • Patients with previous injection experiences
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported